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It is well established that people are exposed to
a diverse and dynamic mixture of environ-
mental stressors as a routine part of their exis-
tence, and there is clear evidence that toxicity
can be modiﬁed by simultaneous or sequential
exposure to multiple environmental agents
(Carpenter et al. 2002; Hertzberg and
Teuschler 2002). We know, for example, that
exposure to tobacco smoke and asbestos
(Erren et al. 1999) or radon (Morrison et al.
1998) multiplicatively increases the risk of
lung cancer over what would be expected
from simple addition of the effects from the
agents acting separately. Similarly, exposure to
aflatoxin-contaminated food and hepatitis B
infection greatly increases the risk of hepato-
cellular carcinoma (Kuper et al. 2001), expo-
sure to noise and toluene results in higher risk
of hearing loss than from either stressor alone
(Franks and Thais 1996), exposure to poly-
cyclic aromatic hydrocarbons and ultraviolet
radiation increases toxicity to aquatic organ-
isms (Oris and Geisy 1985), and adults with
increased perceived stress (Cohen et al. 1999)
and children of parents experiencing stress
(Boyce et al. 1995) are more susceptible to
viral respiratory infections. 
Risk assessments have, nevertheless,
focused mainly on the narrow question of
harm from exposure to individual chemicals
in a specific environmental medium via a
single route or pathway [U.S. Environmental
Protection Agency (EPA) 2003]. Although
there is an expanding body of work on
cumulative exposures and combined effects
on people (Agency for Toxic Substances and
Disease Registry 2002; Carpenter et al. 2002;
Monosson 2005; U.S. EPA 2000; Yang
1994) and on ecosystems (Bryce et al. 1999;
Dale et al. 1998; U.S. EPA 1998), adequate
and appropriate data are rarely available to
conduct a rigorous assessment of cumulatve
risk. In this article, we briefly review three
fundamental and interrelated questions that
must be addressed as part of the cumulative
risk assessment process. Which environmen-
tal mixtures are most important from a public
health perspective? What is the nature and
magnitude of cumulative exposures for popu-
lations of interest? What is the mechanism
and consequence of combined effects on
exposed populations? 
Which Environmental Mixtures
Are Most Important?
For our purposes, the terms “agent” and “stres-
sor” are used interchangeably to mean any bio-
logical (e.g., Staphylococcus aureus, Penicillium
funiculosum), chemical [e.g., benzene, lead,
dichlorodiphenyltrichloroethane (DDT)], or
physical (e.g., heat, noise, radiation) entity, or
psychosocial demand or challenge (e.g., family
conﬂict, unemployment, neighborhood crime)
that can, either by its presence or absence,
cause deleterious effects in an organism, com-
munity, or population (U.S. EPA 2003). A
mixture is deﬁned as a combination of two or
more environmental agents. 
Types of mixtures. Faced with the array,
complexity, and variability of real-world mix-
tures, scientists have found it useful to distin-
guish among three generic types: similar,
defined, and coincidental mixtures (Sexton
et al. 1995a; Vouk et al. 1987). Similar mix-
tures (see Supplemental Material, Appendix 1,
Table 1-1; http://www.ehponline.org/
docs/2007/9333/suppl.pdf) are composed of
agents that have comparable properties, such
as chemical structure, mechanism of toxic
action, or toxicologic end point (e.g.,
organophosphate pesticides). Similar mix-
tures, especially those with a common mode
of toxicity, and for which potency of all can be
summarized in terms of dosage of one speciﬁc
reference chemical in the group, are the most
amenable to quantitative assessment of cumu-
lative health risks (U.S. EPA 2000, 2002c; van
den Berg et al. 1998). 
Defined mixtures (see Supplemental
Material, Appendix 1, Table 1-2; http://
www.ehponline.org/docs/2007/9333/suppl.
pdf) are created at a given time and place,
have a reasonably defined composition, at
least when emitted (before the action of
chemical and biological modiﬁcations in the
environment), and have components that do
not necessarily possess similar properties (e.g.,
diesel exhaust). They are more complicated
than similar mixtures but still provide a sim-
plified conceptual construct that focuses
attention on a manageable and meaningful
segment of real-world environmental stres-
sors. Quantitative risk assessments have been
conducted for selected defined mixtures,
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Differential exposure to mixtures of environmental agents, including biological, chemical, physical,
and psychosocial stressors, can contribute to increased vulnerability of human populations and eco-
logic systems. Cumulative risk assessment is a tool for organizing and analyzing information to eval-
uate the probability and seriousness of harmful effects caused by either simultaneous and/or
sequential exposure to multiple environmental stressors. In this article we focus on elucidating key
challenges that must be addressed to determine whether and to what degree differential exposure to
environmental mixtures contributes to increased vulnerability of exposed populations. In particular,
the emphasis is on examining three fundamental and interrelated questions that must be addressed
as part of the process to assess cumulative risk: a) Which mixtures are most important from a public
health perspective? and b) What is the nature (i.e., duration, frequency, timing) and magnitude (i.e.,
exposure concentration and dose) of relevant cumulative exposures for the population of interest?
c) What is the mechanism (e.g., toxicokinetic or toxicodynamic) and consequence (e.g., additive, less
than additive, more than additive) of the mixture’s interactive effects on exposed populations? The
focus is primarily on human health effects from chemical mixtures, and the goal is to reinforce the
need for improved assessment of cumulative exposure and better understanding of the biological
mechanisms that determine toxicologic interactions among mixture constituents. Key words: chemi-
cal mixtures, combined effects, cumulative exposure, cumulative risk, environmental mixtures, inter-
action mechanisms, multiple stressors, risk ssessment. Environ Health Perspect 115:825–832 (2006).
doi:10.1289/ehp.9333 available via http://dx.doi.org/ [Online 24 January 2007]including environmental tobacco smoke, coke
oven emissions, and diesel engine exhaust
(U.S. EPA 2003).
Coincidental mixtures (see Supplemental
Material, Appendix 1, Table 1-3; http://
www.ehponline.org/docs/2007/9333/suppl.
pdf) occur by happenstance at a time or place
of interest (e.g., urban air pollution). Mixture
constituents do not necessarily have similar
properties; the composition is not necessarily
constant; and the mixture may occur fre-
quently, occasionally, or rarely. Coincidental
mixtures are the most complex of the three
categories because they necessarily include all
environmental stressors that are relevant for
the toxicologic end point of concern. Despite
the inherent complexity associated with coin-
cidental mixtures, preliminary and screening-
type cumulative risk assessments have been
attempted for certain real-world situations,
including urban air pollution (Caldwell et al.
1998; Fox et al. 2004; Morello-Frosch et al.
2000; Tam and Neumann 2004), consump-
tion of home-grown vegetables by urban
populations (Hough et al. 2004), and adverse
impacts on speciﬁc ecosystems (Gentile et al.
2001; Obery and Landis 2002; Suter 1999;
U.S. EPA 2002a, 2002d). 
It is important to understand that, in con-
trast to similar mixtures, standard dose-addi-
tion formulae may not accurately predict the
results of interactions for coincidental mix-
tures. Furthermore, the strength of interactive
effects may differ as a function of the doses of
the components depending on any nonlinear-
ities in the dose–response relationships for the
biological processes affected by the compo-
nents. A further complication is that the tem-
poral characteristics of both exposures and
resulting alterations in biological processes
may differ for different components of coinci-
dental mixtures. 
The three categories described above
rovide a practical nomenclature for describing
the types of mixtures that have been or will be
the subject of cumulative risk assessments.
Similar mixtures, which are defined by how
they are assessed, reduce the complexity of the
problem by artificially limiting the scope of
the inquiry to a manageable number of stres-
sors with similar characteristics. Deﬁned mix-
tures, which are defined by how they are
generated, are source-oriented, and lessen the
difficulties by focusing exclusively on a dis-
tinct type of real-world mixture, such as emis-
sions from certain sources or source
categories. Coincidental mixtures, which are
defined by the scope of the problem to be
addressed, are receptor-oriented and therefore
focus on people or ecosystems. They are the
most complicated because they potentially
include any and all relevant stressors to which
people and ecosystems are exposed during
day-to-day activities. It is worth noting that
the the U.S. EPA guidance on risk assessment
for chemical mixtures also distinguishes
among mixtures that can be assessed a)a s
substances in themselves, b) by analogy to
comparable mixtures, and c) as a collection of
individual components (U.S. EPA 2000)
Identifying high-priority mixtures.
Priorities must be established to identify the
environmental mixtures of greatest public
health concern because it is impossible to
characterize even a small fraction of the actual
mixtures that are normally encountered dur-
ing everyday life, As a first step, four attrib-
utes can be used to distinguish mixtures that
deserve attention from researchers, risk asses-
sors, and regulators: scope of exposure, nature
of exposure, severity of effects, and likelihood
of interactions. Based on these criteria, a
high-priority mixture would have the follow-
ing characteristics:
• Scope of exposure: A large number of organ-
isms, communities, or populations are
exposed to the mixture and/or a signiﬁcant
number of susceptible organisms, communi-
ties or populations are exposed to the mixture.
• Nature of exposure: The magnitude, dura-
tion, frequency, and/or timing of exposure
to the mixture raises concerns about possi-
ble adverse effects.
• Severity of effects: The known or suspected
adverse outcomes of exposure to the mixture
are of a nature or consequence that suggests
risks are likely to be unacceptable.
• Likelihood of interactions: Adverse effects
from exposure to the mixture are not likely
to be characterized adequately based on
knowledge of known effects of individual
mixture components acting separately.
For similar mixtures (see Supplemental
Material, Appendix 1, Table 1-1; http://
www.ehponline.org/docs/2007/9333/suppl.
pdf), application of these criteria suggests that
among the high-priority mixtures are persis-
tent organochlorine pollutants. These include
polychlorinated dioxins, polychlorinated
dibenzofurans, and polychlorinated biphenyls
(PCBs) (Birnbaum and DeVito 1995; Hamm
et al. 2003; Walker et al. 2005); polycyclic
aromatic hydrocarbons (PAHs) including
benzo[a]pyrene, benzo[f ]fluoranthene, and
dibenzo[ah]anthracene (Armstrong et al. 2004;
Bostrom et al. 2002; Central Pollution Control
Board 2003; Department of the Environment
and Heritage 1999); organophosphate (OP)
pesticides including chlorpyrifos, diazinon,
azinphos methyl, and oxydemeton-methyl
(Barr et al. 2004; U.S. EPA 2002c); hormon-
ally active agents including some organohalo-
gens, phthalate acid esters, bisphenol, PCBs,
and phytoestrogens (Damstra et al. 2002;
Safe et al. 2002); and neurotoxins including
lead (Pb), mercury (Hg), organic solvents,
organochlorine pesticides, and PCBs
(Needham et al. 2005a; Tilson 2000). 
Among deﬁned mixtures (see Supplemental
Material, Appendix 1, Table 1-2; http://www.
ehponline.org/docs/2007/9333/suppl.pdf),
examples of high-priorities are drinking water
disinfection by-products including tri-
halomethanes, haloacetic acids, and haloace-
toniriles (Feron et al. 2002; Simmons et al.
2002); diesel exhaust including hundreds of
chemicals in either particulate or gaseous
phase (Health Effects Institute 1995; U.S.
EPA 2002b); and coal-fired power plant
emissions including particulate matter, heavy
metals, nitrogen oxides, and sulfur dioxide
(Levy et al. 2002; Sram et al. 1996).
Among the virtually infinite number
of possible coincidental mixtures (see
Supplemental Material, Appendix 1, Table
1-3; http://www.ehponline.org/docs/2007/
9333/suppl.pdf) that occur in the real world,
there are three obvious examples of high-pri-
ority exposures. First, workers in industries
such as construction and underground min-
ing are likely to be exposed to myriad haz-
ardous agents (Tarcher 1992). Categories of
potential stressors that can contribute to these
complex mixtures are listed in Supplemental
Material, Appendix 1, Table 1-4 (http://
www.ehponline.org/docs/2007/9333/
suppl.pdf), and examples of the kinds of mix-
tures typically encountered in various industries
are provided in Supplemental Material,
Appendix 1, Table 1-5 (http://www.ehponline.
org/docs/2007/9333/suppl.pdf) (Tarcher 1992). 
Second, in contrast to workers, who tend
to be relatively young and healthy, and who
spend only 40 hr per week on the job, most
people, including the sick, the elderly, and the
very young, typically spend a signiﬁcant por-
tion of each day indoors at home (Baker et al.
2001; Samet and Spengler 1991). As shown
in the Supplemental Material, Appendix 1,
Table 1-6 (http://www.ehponline.org/docs/
2007/9333/suppl.pdf), there are many cate-
gories of environmental stressors commonly
found inside residences, and cumulative expo-
sures and associated risks can be unacceptably
high (California Air Resources Board 2005). 
Third, as illustrated in Supplemental
Material, Appendix 1, Table 1-7 (http://
www.ehponline.org/docs/2007/9333/suppl.
pdf), many poor people, a disproportionate
fraction of whom are people of color, live in
blighted inner-city neighborhoods where they
are exposed to a complex concoction of stres-
sors. In addition, these people are also more
likely to be employed in hazardous occupa-
tions, lack knowledge of environmental
health issues, smoke cigarettes and drink alco-
hol, have a substandard diet, lack access to
adequate health care, and, in general, live
more stressful and less healthful lives.
(Evans and Kantrowitz 2002; Evans and
Marcynyszyn 2004; Gee and Payne-Sturgis
2004; Institute of Medicine 1999; O’Neill
Sexton and Hattis
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What Is the Nature and
Magnitude of Cumulative
Exposure?
Concepts and definitions. Cumulative expo-
sure refers to past and/or present exposure
(including relevant background exposure) of
an entity to multiple environmental stressors
occurring by all pertinent routes, pathways,
and sources. Exposure to mixture constituents
need not be necessarily contemporaneous to
produce cumulative impacts, thus it is vital to
be cognizant of how the presence or persis-
tence of multiple stressors (or their conse-
quences) contributes to the series of biological
events that cause adverse effects. Cumulative
exposure assessment is the appraisal of simul-
taneous, overlapping, and/or sequential expo-
sure to multiple environmental stressors that
may contribute to harmful outcomes. A
major motivation for conducting cumulative
exposure assessments is to help determine
whether differential exposure of individuals,
communities, or populations to environmen-
tal mixtures causes increased vulnerability
(Figure 1). Differential exposure refers to dif-
ferences in the magnitude, duration, fre-
quency, or timing of exposure as well as
dissimilarities in historical and background
exposure levels and related body burden that
can affect the likelihood, nature, and severity
of adverse effects. The term “vulnerability” is
used here to mean the intrinsic propensity of
an exposed entity to experience adverse effects
from external agents, events, perturbations, or
stresses (U.S. EPA 2003). A brief overview of
important cumulative exposure issues is pro-
vided in Supplemental Material, Appendix 2
(http://www.ehponline.org/docs/2007/9333/
suppl.pdf).
Cumulative exposure assessment is method-
ologically and computationally more complex
than traditional single-chemical, single-
pathway, single-source assessments because
assessors must take account of a) temporal con-
cordance (exposure to two or more stressors
within a timeframe consistent with their toxi-
cologic mode(s) of action); b) spatial concor-
dance (contact with two or more stressors
within a geographic area or physical space con-
sistent with the possibility of cumulative expo-
sure); and c) sociodemographic concordance
(cumulative exposure of potentially vulnerable
groups such as pregnant women, fetuses, chil-
dren, the sick, the elderly, and the socioeco-
nomically disadvantaged, which occurs across
both temporal and spatial dimensions)
(Mileson et al. 1999; U.S. EPA 2003).
In practice, measuring or estimating con-
current exposure to multiple stressors is not
straightforward, even if the toxicologically rel-
evant temporal, spatial, and sociodemographic
aspects are known. For example, cumulative
exposure assessment necessitates assessment of
background exposure. Although the term
“background exposure” has been used to
describe a variety of conditions and situations,
we use it here to mean the combined exposure
to toxicologically relevant environmental stres-
sors that are not necessarily the focus of the
assessment but that may contribute to the
cumulative risks being considered. Under this
deﬁnition, both naturally occurring (e.g., ter-
penes emitted by pine trees) and artificially
created (e.g., xylenes emitted by both mobile
and stationary anthropogenic sources) com-
pounds can be included, their inﬂuence may
be localized or widespread in the environment,
and their sources may or may not be known.
The important point is that background expo-
sures, which can occur across all exposure
sources, pathways, and routes, must be evalu-
ated as an intrinsic part of cumulative expo-
sure assessment, if for no other reason than to
exclude them as a significant contributor to
the risks being assessed.
In addition to background exposures, it is
usually also necessary to determine historical
exposures as well. Determining the exposure his-
tory for the period of interest often means that
we are concerned about exposures that occurred
10 or more years ago. This is a difﬁcult chal-
lenge for exposure assessors because relatively
scant exposure-related information is available
for most real-world mixtures of public health
concern. In some cases, past exposure (over
months or years) to persistent compounds can
be estimated from concentrations of the chemi-
cals, their metabolites, or reaction products in
bodily tissues or ﬂuids (e.g., Pb in blood). Other
nonpersistent compounds (e.g., benzene), how-
ever, may produce adverse effects that occur
long after the chemicals are no longer present in
the body, although some of these chemicals do
produce DNA adducts or protein adducts that
can be used as exposure- and/or early-effect bio-
markers (Sexton et al. 2004a). In general, accu-
rate assessment of historical exposure to mixture
constituents over the past several years, let alone
the past several decades, is problematic. It is
important to remember that exposures need not
have actual temporal overlap in order to create
interactions by changing the vulnerability of
sensitive receptors.
Because the monitoring data necessary for
retrospective exposure assessment are lacking in
most cases, assessors typically must rely on less
exact methods to estimate historical exposure,
such as interviews, questionnaires, documen-
tation of occupational histories, centralized
monitoring data for air and water pollutants,
or construction of exposure scenarios (NRC
1991; Sexton et al. 1995b, 2004a). However,
ongoing advances in technology, data collec-
tion methods, and scientific understanding
hold out the promise of more accurate assess-
ments in the future. 
Six trends beneﬁting cumulative exposure
assessment. There are currently at least six
trends that suggest cumulative exposure assess-
ment may, over time, become easier and more
straightforward. First, there are ongoing efforts
to establish state and federal environmental
health tracking systems that provide for the sys-
tematic collection, integration, analysis, inter-
pretation, and dissemination of information
about environmental hazards, including
sources, environmental concentrations, expo-
sures, doses, and potentially related health
effects. The creation of linked monitoring sys-
tems, databases, and registries offers the
prospect of better data on cumulative exposures
and improved understanding of the connection
between combined exposures and chronic dis-
eases such as diabetes, arteriosclerosis, and can-
cer (Litt et al. 2004; McGeehin et al. 2004).
Second, large-scale prospective studies,
such as the National Children’s Study (NCS)
(if eventually funded), will provide data on
exposure to multiple environmental agents
during various stages of the life cycle. The
NCS is planned to be a national longitudinal
study of environmental inﬂuences, including
physical, chemical, biological, and psycho-
logic stressors, on children’s health and devel-
opment from conception to early adulthood.
Multiple exposure measures will be collected
on a cohort of 100,000 children, and the
results will enable risk assessors to more accu-
rately assess children’s cumulative exposure to
Cumulative exposure and related combined effects
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Figure 1. Schematic representation of possible effects from differential cumulative life-time exposure on
(A) cumulative exposure and morbidity and (B) cumulative exposure and mortality [adapted from NRC (2002)].
Abbreviations: Δt, difference in time at age of death; Te, age at onset or death for individual A; Te, age at death
for individual A
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0a broad range of environmental stressors (Barr
et al. 2005; Needham et al. 2005b).
Third, the growing availability of speciﬁc
and sensitive biologic markers of exposure,
effects, and susceptibility provides an increas-
ingly effective means of assessing cumulative
exposure and, potentially, associated health
effects (Needham and Sexton 2000; Sexton
2006; Sexton et al. 2004a, 2004b, 2005, 2006;
Weis et al. 2005). A case in point is the
“National Report on Human Exposure to
Environmental Chemicals” (the National
Report), which is published periodically by the
Centers for Disease Control and Prevention
(2005). The National Report provides reference
ranges for exposure to multiple chemicals
among the U.S. population, subdivided by age,
sex, and ethnicity. The ﬁrst report was published
in March 2001, the second in January 2003,
and the third, which presents exposure data for
148 chemicals, in July 2005. Collectively, these
data provide an indication of the range of
nonoccupational exposure for both individual
chemicals (e.g., Pb, Hg) and similar mixtures of
chemicals (e.g., organochlorine-based pesticides,
organophosphate-based pesticides, carbamate-
based pesticides, PCBs, dioxins, furans, phtha-
lates, phytoestrogens). Although all chemicals
and chemical classes are not measured in the
same individuals, and data for children younger
than 12 years are only available for a few chemi-
cals such as lead and mercury, the National
Report provides an invaluable resource for
approximating distributions of body burden lev-
els, identifying high-priority exposures, and
understanding how levels of multiple chemicals
are changing over time. 
Fourth, advances in biomedical sciences
including ongoing developments in genomics,
proteomics, metabolomics, transcriptomics,
nanotechnology, and medical imaging
promise to eventually revolutionize the assess-
ment of cumulative exposure and related
health risks. These methods provide new
quantitative tools for assessing biological
response to cumulative environmental expo-
sure, thereby affording expanding opportuni-
ties to gain an in-depth understanding of
exposure-related events that occur along the
pathway from human contact with environ-
mental mixtures to eventual environmentally-
induced discomfort, dysfunction, disability,
disease, and death. For example, the National
Institute of Environmental Health Sciences
(Research Triangle Park, North Carolina) is
currently developing an “exposure biology”
initiative aimed at advancing knowledge of
gene–environment interactions in model dis-
ease processes so that we can attain the same
level of individual-level precision as is being
achieved through the sequencing of the
human genome (Schwartz et al. 2005).
Fifth, a variety of innovative technologies,
including improved environmental sensors
(Weis et al. 2005), geographic information
systems (Meliker et al. 2005; Weis et al.
2005), and Bayesian statistical techniques
(Burstyn and Kromhout 2002; Ramachandran
2001; Ramachandran and Vincent 1999),
offer the possibility of enhanced retrospective
assessment of historical exposure. For example,
microscale sensors, such as tiny, inexpensive,
personal exposure monitors that use fluores-
cence or cell function to detect chemicals in
nanoscale sample volumes, and macroscale
sensors, such as infrared radiation–based mon-
itors that detect sulfur and nitrogen oxides in
industrial-stack efﬂuents, are making it easier
and less expensive to measure actual exposures
as well as environmental concentrations (Weis
et al. 2005). Spatiotemporal visualization tools
have been used to produce smooth, continu-
ous space–time maps that assign exposure esti-
mates through a spatial query procedure, as
well as smooth, continuous temporally variant
histograms and scatter plots that allow for
examination of relationships between expo-
sure-related variables at any moment in time
(Meliker et al. 2005). Bayesian statistical
approaches, which take prior information into
account in determination of probabilities,
have been used to assess occupational exposure
retrospectively as a function of space and time
through systematic synthesis of a combination
of expert judgments, exposure models, histori-
cal data about workplace conditions, and
available exposure measurements (Burstyn and
Kromhout 2002; Ramachandran 2001;
Ramachandran and Vincent 1999). 
Sixth, numerous computer models have
been developed by federal agencies, academic
researchers, and private-sector scientists to
simulate longitudinal exposures to multiple
chemicals via multiple pathways from multi-
ple sources. These ongoing efforts have neces-
sarily shifted the focus from traditional,
source-oriented approaches to receptor-ori-
ented approaches (Price and Chaisson 2005).
Currently, there are several PC-based cumula-
tive exposure models that can be used to cal-
culate exposure histories for chemical
mixtures, including the Lifeline, Calendex,
CARES (Cumulative and Aggregate Risk
Evaluation System), SHEDS (Stochastic
Human Exposure and Dose Simulation), and
APEX (Air Pollutants Exposure) models
(Price and Chaisson 2005). As more data
become available and understanding of cumu-
lative exposure improves, the accuracy of
results will get better and the use of these and
subsequent models will increase.
What is the Mechanism and
Consequence of Interactive
Effects?
In addition to cumulative exposure evaluation,
understanding mechanisms of interaction
among mixture constituents is important for
realistic risk assessment because mechanistic
knowledge allows for quantitative predictions
of the nature and consequences of co-exposure
to different stressors. Morevoer, mechanistic
framing of relevant questions is more produc-
tive for research planning than simple dose-
addition or response-addition formulae. 
Types of interactive effects. There are
three general types of interactions among
mixture components that can affect toxico-
logic response to the whole mixture (Thomas
et al. 2002; U.S. EPA 2000): 
• Agent-to-agent interactions prior to crossing
the boundaries of an organism can occur
among mixture constituents, such as between
airborne hydrocarbons and NOx (nitrogen
oxide) in the presence of ultraviolet radiation
to produce tropospheric ozone. These sorts of
interactions are not discussed in this article. 
• Toxicokinetic interactions, which occur
once mixture constituents have crossed an
organism’s boundaries, can take the form of
enhancement or inhibition of absorption,
distribution, metabolism, and elimination
of one or more mixture components. 
• Toxicodynamic interactions as a result of
exposure to mixture constituents, their
metabolites, or reaction products can alter
mechanisms of damage, repair, compensa-
tion and signaling. 
The effect of interactions (or lack thereof)
among mixture components on empirically
observable dose–response relationships for toxi-
city can be divided into four broad categories:
independence, dose additivity, synergism, and
antagonism (Hertzberg and Teuschler 2002;
U.S. EPA 2003). If agents in the mixture act
independently (which is to say that they are
unconnected in any way), then the mixture tox-
icity is qualitatively and quantitatively equiva-
lent to their separate distinct effects—essentially
“response additivity.” If the mixture con-
stituents do not act independently (e.g., they
have a similar mechanism of toxic action) but
no signiﬁcant interactions occur, then the toxi-
cologically relevant dose is considered to be
equivalent to the sum of individual constituent
doses. This situation is referred to as “dose addi-
tion” or “additive dose.” When the toxic effect
of the mixture is greater than that expected for
the sum of individual constituent doses, which
is that effects of combined doses are more-than-
additive, the interactions are said to be synergis-
tic. Conversely, when the toxic effect of the
mixture is less than that expected under the
dose additivity assumption, the interactions are
said to be antagonistic (Hertzberg and
Teuschler 2002). In the subsequent discussion
we focus on identifying instances where syner-
gism or antagonism may occur, and describing
the responsible interaction mechanisms.
Toxicokinetic interactions. Toxicokinetic
interactions occur when one factor affects the
transport or metabolism of an environmental
Sexton and Hattis
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tion and time profile of the ultimate active
metabolite at the internal body site of action
for causing some adverse effect. Examples
of this include inhibition or induction of
active transport or metabolizing systems.
Physiologically based pharmacokinetic (PBPK)
models, which are the basis for mathematical
analysis of pharmacokinetic interactions, are
discussed in the Supplemental Material,
Appendix 3 (http://www.ehponline.org/docs/
2007/9333/suppl.pdf). Selected examples of
toxicokinetic interactions are discussed below.
Enzyme and active transport induction.
The major ways that exposure to one chemi-
cal can change the metabolism of another
chemical follow from the simple molecular
picture underlying Michaelis-Menten kinetics
(See Supplemental Material, Appendix 3;
http://www.ehponline.org/docs/2007/9333/
suppl.pdf). If exposure to one substance (e.g.,
some PCBs) causes enhanced transcription
and translation of a cytochrome P450 (CYP)
enzyme that metabolizes another [e.g., the
induction of CYP2E1 by ethanol (Ingleman-
Sundberg et al. 1994) or nicotine (Micu et al.
2003)], one would expect an increase in Vmax
(maximum rate of production of metabolic
product) for the second chemical. This would
decrease the local and systemic availability of
the parent (substrate) chemical and increase
the rate of production of an active metabolite
of the parent chemical, if the active metabo-
lite results from metabolism by the induced
CYP enzyme. 
Competitive inhibition and other vari-
ants. If two substrates bind to the same active
site on the same enzyme so that binding of
one substrate prevents the binding of the
other, then the two substrates are said to be
“competitive” inhibitors. In the context of the
Michaelis-Menten enzyme kinetic equation,
the effect of this competition is to increase the
Km (the Michaelis constant, defined as the
substate concentration that elicits half the
maximum rate of production of metabolic
product) by an amount that depends on the
relative binding afﬁnity to the active site and
the concentration of the inhibiting/compet-
ing substrate. In addition to competitive inhi-
bition, there are at least two other modes of
interaction—“uncompetitive” and “noncom-
petitive”—that have been described within
the classic Michaelis-Menten framework (see
Supplemental Material, Appendix 4; http://
www.ehponline.org/docs/2007/9333/
suppl.pdf). 
Modification of uptake and local elimi-
nation. Sometimes the cumulative changes
caused by one toxicant have implications for
internal exposure to another toxicant. To
illustrate, particles are cleared from the lung
in two phases with very different half-lives,
depending on the site of deposition. Particles
deposited on the ciliated tracheobronchial
epithelium are swept up the bronchial tree out
of the lung and swallowed with half-lives on
the order of 3 hr in never-smokers (Möller
et al. 2004). By contrast, particles deposited in
the deep lung (alveoli and terminal respiratory
airways) must be cleared by processes involv-
ing macrophages, with half-lives of 100 days
or more in nonsmokers. In smokers, however,
clearance times increase linearly with the
cumulative number of pack-years of cigarette
smoking (Bohning et al. 1982; Möller et al.
2001). Such reductions in long-term clearance
are likely to increase the chronic accumulation
of small particles and enhance associated
effects (Hattis and Silver 1994).
Toxicodynamic interactions. Toxico-
dynamic interactions are generally less under-
stood than toxicokinetic interactions. A
systematic way to approach this subject is in
terms of levels of biological organization:
• Subcellular phosphorylation cascade (“second
messenger”) signaling processes operating on
a time scale of seconds to minutes. 
• Cellular processes involving gene transcrip-
tion and translation, and most genomic
defense mechanisms (DNA repair, apopto-
sis, cell cycle arrest), typically operating on a
time scale of minutes to hours.
• Cell-neighbor (“juxtracrine”) communica-
tion processes (contact inhibition and other
signaling among adjacent cells via “gap
junctions”).
• Organ- and tissue-level control and feed-
back processes influencing the choices of
individual cells among symmetrical and
asymmetrical proliferation of stem cells, dif-
ferentiation, long term survival and func-
tioning without proliferation for end-state
differentiated cells, and apoptosis.
• Local functional control to support short-
term tissue needs (e.g., dilation of blood
vessels in response to a local drop in oxygen
tension, perhaps from local muscle activity).
• Intersystem feedback controls via neural and
endocrine signaling.
In the discussion below we use this classiﬁca-
tion scheme to provide some examples of tox-
icodynamic interactions.
Subcellular phosphorylation cascade sig-
naling processes. Cells have elaborate internal
signaling systems that mediate rapid (seconds
to minutes) changes as diverse as choices to
respond to DNA damage in various ways, ini-
tiate cell division, or differentiate to express
the end state functions needed in a particular
tissue. Many of these signals involve transfer-
ring phosphate groups to alcoholic amino
acids (e.g. tyrosine, serine) in specific pro-
teins. For example, double-strand DNA
breaks produced by ionizing radiation are ini-
tially sensed and communicated via the phos-
phorylation of the ATM protein (ATM is
“mutated in ataxia-telangiectasia,” a genetic
disease characterized by unusual sensitivity to
ionizing radiation, among other effects). 
Gene transcription/translation and
genomic defense mechanisms. An array of
cellular defenses is induced in response to
genetic damage, thereby creating an opportu-
nity for exposure to one chemical to affect vul-
nerability to another chemical (Bartek and
Lukas 2001). Gene transcription and transla-
tion responses typically occur on a time scale
of minutes to several hours. The end results of
these processes include cell cycle arrest, either
at the boundaries between G1 and S where
DNA begins to be synthesized, or in G2 after
DNA is synthesized but before the cell is com-
mitted to the chromosome separation process
of mitosis. Cell cycle arrest (Shackelford et al.
1999) can be beneﬁcial in allowing more time
for DNA repair before replication-related “ﬁx-
ation” of DNA lesions into essentially perma-
nent changes in the information coded in
DNA (mutations). 
Alternatively, DNA repair can occur by sev-
eral different processes (Hoeijmakers 2001)
including one (methyl–guanine–methyl trans-
ferase) that involves apparently permanent inac-
tivation of a particular protein that serves as
both an enzyme and the acceptor for the
removed methyl group. Regeneration of the
active form of this enzyme through new synthe-
sis occurs over a period of days, implying that
cells exposed to one alkylating agent may well
be more sensitive to the action of another alky-
lating agent during that interval (Gerson 1988).
Apoptosis—or programmed cell suicide—is a
backstop mechanism that appears to be particu-
larly prominent as a response in stem cells capa-
ble of indefinite proliferation. Alternatively,
DNA damage can induce some cells to enter a
senescent state in which they are permanently
withdrawn from the cell cycle, preventing possi-
ble further mutation to cancer in that cell but
preserving, for a while, some level of differenti-
ated function (Campisi 2005).
Changes in signaling among adjacent cells
via gap junctions. A good example is the inter-
ference with the cell communication via trans-
fer of small molecules across gap junctions
involving connexin proteins. Such inhibition is
thought to be an important mechanism of pro-
motion of cancer cells, releasing the initiated
cells from growth inhibition by untransformed
neighboring cells (Mesnil 2002; Trosko et al.
2004). It is plausible that chemicals acting by
this mechanism may have synergistic interac-
tions with chemicals that act by primary
genetic mechanisms to produce cancer. The
chlorinated insecticides lindane and chlordane
are prime examples of such inhibitors (Caruso
et al. 2005).
Organ and tissue-level control and
feedback processes. Organ- and tissue-level
feedback can influence the choices of stem
cells among symmetrical and asymmetrical
Cumulative exposure and related combined effects
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enchymal-derived tissues are in constant dia-
logue that maintains desirable numbers of
cells at all stages in differentiation, from the
earliest stem cells through rapidly proliferat-
ing progenitor cells to terminally differenti-
ated functional cells. These processes have
been studied most intensely in intestinal sys-
tems, where a cell’s position in the structure
of the proliferating crypt and functional villus
provides information on each cell’s position
in the stem-to-differentiated cell sequence
(Sancho et al. 2004). Among the mediators of
tissue responses to radiation and probably
other sources of oxidative stress is transform-
ing growth factor beta (TGF-β). This nor-
mally resides outside of cells in close
association with a specific inhibitor. The
inhibitor is released on exposure of intestinal
tissue to radiation and likely to other oxida-
tive stimuli, leading to increased apoptosis
and probably other defensive responses
(Thavaraj et al. 2005). TGF-β also regulates
growth and apoptosis in other contexts
(Arsura et al. 2003), including development
(Tsutsumi et al. 2002). 
Changes in cell replication. Enhancement
of cell replication may be one of the more
common sources of extreme high-dose nonlin-
earities in chronic animal testing and, when
present in humans due to an interacting factor
(e.g., viral infections), could be a source of
synergistic interactions in people. For exam-
ple, it is well documented that there is a syner-
gistic interaction between aflatoxin exposure
and hepatitis B infection in the induction of
liver cancer (Kew 2003). The precise mecha-
nism has not been elucidated, but it is likely
that hepatitis B infection induces increased
cell replication, making the cells more vulnera-
ble to mutation by aﬂatoxin B partly because
of reduced time for DNA repair. 
Neural signaling. Neurons communicate
by secreting transmitter substances across small
spaces between adjacent cells. Some environ-
mental toxicants such as organophosphate and
carbamate pesticides, as well as many impor-
tant drugs, act by affecting transmitter-medi-
ated communication in one way or another.
The organophosphate and carbamates are anti-
cholinesterase agents that act by binding to the
active site of acetylcholinesterase and inhibiting
its action, leading to greater persistence of the
acetylcholine, and hence longer transmission of
the signal.
Endocrine and hormonal signaling.
Continuing stimulation of an endocrine path-
way with an agonist (a drug or environmental
chemical that binds to a receptor and stimu-
lates it to induce a signaling cascade similar to
the natural ligand) will tend to induce some
offsetting desensitization of the system. This
can take the form of a reduction in the num-
ber of the excessively stimulated receptors
(down-regulation), which reduces the
response of the system to the natural ligand
(or other external agonists) or other mecha-
nisms of desensitization such as down-regula-
tion of downstream steps in the biological
response (such as altering the strength of the
phosphorylation or second-messenger cascade
that normally follows receptor binding). 
Autoimmune responses and other
learned responses. Immune recognition
mechanisms rely on co-stimulation of ulti-
mate effector cells by both specific antigens
and less specific chemical mediators, which
signal the presence of nonspeciﬁc damage by
an invading organism. Even exposure to rela-
tively chemically inert environmental pollu-
tants such as silica dust or to chemicals that
are only slowly metabolized to potentially
reactive agents such as hexachlorobenzene can
affect the immune response, which in turn
can increase vulnerability to other environ-
mental exposures (Pieters et al. 2003). See
Supplemental Material, Appendix 5 (http://
www.ehponline.org/docs/2007/9333/
suppl.pdf), for a brief discussion of immune-
mediated drug-induced liver diseases. 
Developing better understanding of com-
bined effects. Development of a more compre-
hensive picture of vulnerability changes in
response to cumulative exposure to environ-
mental mixtures will depend on enhanced
quantitative understanding of mechanisms that
underpin the system of feedback processes con-
trolling vital systems in humans and other
organisms. For long-term interactions, it is par-
ticularly important to understand potential
vulnerabilities in the systems by which our
homeostatic “set points’ are themselves “set”
during development, then maintained through
growth maturation and adulthood, and ﬁnally
start to break down with advancing age. Set-
point systems necessarily involve three compo-
nents: sensors that monitor the levels of key
parameters; signaling mechanisms that com-
municate needs for adaptive responses; and
effector mechanisms that take action to offset
detected departures from established set points.
These set-point systems must necessarily oper-
ate on different scales of biological organiza-
tion, time, and physical distance.
Biological organization. There are at least
four distinct levels of biological organization:
a) the subcellular level, which, for example,
controls activation versus silencing of portions
of the genome (apparently subject to disrup-
tion in very early embryos prior to organo-
genesis via exposures to agents known for
their DNA-damaging properties; Kimmel
et al. 1993); b) the cellular level, where there
must be controls on pool sizes (concentra-
tions) and turnover rates of key metabolic
intermediates, and the adenosine triphosphate
energy currency of the cell; c) the tissue/organ
level, where similar and different cell types
coordinate their activities to perform physio-
logical functions at required rates, such as the
control of blood electrolyte levels by the kid-
ney, the orderly sequential contraction of
muscle cells in different parts of the heart,
and the coordinated processing of informa-
tion from the retina to form and identify an
image of an object by the brain; d) the sys-
tem/organism level, where the activities of
multiple systems must be coordinated to
accomplish centrally-directed tasks (e.g., the
regulation of heart rate, breathing rate, dila-
tion of numerous blood vessels, and muscle
activity needed to play soccer).
Time. Biological systems are known to
undergo regular adaptive ﬂuctuations in time,
with some changes tied to external events
(e.g., circadian rhythms coinciding with
light–dark cycles) and others to internal
events (e.g., cell cycle, menstrual cycle). Much
attention has been focused recently on under-
standing the daily, weekly, and yearly cycles
in acute coronary events, which can be modi-
ﬁable by aspirin and beta blockers, and giving
hope that causal mechanisms can eventually
be determined (Strike and Steptoe 2003).
Physical distances. Some signaling and
feedback systems must operate on a diversity
of scales, including: micron or submicron
scales (e.g., coordinated transport of chromo-
somes to the centrioles during mitosis);
between adjacent cells (e.g., via gap junction
communication, across synaptic gaps between
neurons, or between neurons and muscle
cells); over larger distances via concentration
gradients of signaling molecules that are
essential for segmentation of the embryo,
establishment of the anterior/posterior
ground plan, distinction between dorsal ver-
sus ventral sides of the embryo, and migration
of future neurons to appropriate locations for
differentiation and synaptogenesis; and,
ﬁnally, over centimeters and even meters via
specific nervous signals and endocrine hor-
mones circulating in the blood.
Development of homeostatic controls is
likely to occur ﬁrst at subcellular levels of bio-
logical organization, operate over short dis-
tances, and respond with relatively rapid time
scales. As development progresses, layers of
control are added in sequence from local
(within organs/tissues, such as the cardiac
pacemaker) to distant (e.g., neural and chemi-
cal signals) (Adolf 1968) and, correspond-
ingly, from shorter to longer response times.
At present, we have inadequate quantitative
understanding of how controls at these differ-
ent levels work, and only an elemental sense of
the initial set up. In short, we need to learn
how the set points are actually set and main-
tained. Furthermore, we need to understand
how programming occurs for allostatic adapta-
tions (Schulkin 2003), which allow the system
to adjust set points in anticipation of changing
Sexton and Hattis
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of a meal).
To better understand these biological
phenomenon, we need to expand research,
especially in the ﬁeld of systems biology (Cho
and Wolkenhauer 2003; Kim and Tidor
2003; Levchenko 2003; Zhu et al. 2004), and
develop and apply new ‘bridging’ biomarkers
of effect that can relate biological conse-
quences across species (MacGregor 2003). As
new methods and tools become available, risk
analysis of and time-related adverse effects
will evolve beyond current rudimentary
approaches, such as modifying data on no
observed adverse effect level/lowest observed
adverse effect level using uncertainty factors,
and the more recent benchmark dose meth-
ods (Allen et al. 1994). A brief summary of
currently available methods for assessing
cumulative health risk from chemical mix-
tures, along with comments on their strengths
and weaknesses, is provided in Supplemental
Material, Appendix 6 (http://www.ehponline.
org/docs/2007/9333/suppl.pdf).
Conclusions
Cumulative risk assessment is currently ham-
pered by three interrelated problems:
a) Relatively little is known about the magni-
tude, duration, frequency, and timing of
cumulative exposure to important environ-
mental mixtures. b) Scant evidence is available
on whether mixture-related effects are antago-
nistic, synergistic, or additive at exposure levels
typically encountered by people. c) There is
inadequate knowledge and insufﬁcient under-
standing about interactive mechanisms of toxi-
city that occur among mixture constituents. In
the near-term, quantitative assessment of
cumulative risks depends not only on targeted
research but also on development of science-
based methods and procedures for using exist-
ing exposure and effects data to characterize
mixture-related health risks with an acceptable
degree of precision. This will unavoidably
involve science policy decisions about how
best to bridge the gap between the scarcity of
hard scientiﬁc evidence and the need to esti-
mate cumulative risks as an integral part of
risk management decisions.
Cumulative risk assessment will be most
useful to decision makers when it can help
answer a fundamental question: “Do the uncer-
tainty/safety factors built into the conventional
risk assessment process adequately protect pub-
lic health and ecologic resources from cumula-
tive effects with a sufﬁcient margin of safety?”
To be relevant, therefore, cumulative risk assess-
ment must provide guidance about which, if
any, of the innumerable environmental mix-
tures that are part of our day-to-day lives repre-
sent important health risks, where “important”
means there is a reasonable likelihood that com-
bined effects of mixture constituents at realistic
exposure levels constitute a serious health risk
that is not adequately accounted for by tradi-
tional risk assessment methods.
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